Piccart MJ - Search Results

1

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].

Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Penault-Llorca F, Piccart MJ, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E. Cardoso F, et al. Among authors: piccart mj. Breast. 2017 Apr;32:269-270. doi: 10.1016/j.breast.2017.01.001. Epub 2017 Jan 18. Breast. 2017. PMID: 28109648 No abstract available.

2

Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer Center.

Kaye SB, Piccart M, Aapro M, Kavanagh J. Kaye SB, et al. Eur J Cancer. 1995;31A Suppl 4:S14-7. doi: 10.1016/0959-8049(95)00361-l. Eur J Cancer. 1995. PMID: 7577099 Clinical Trial.

3

Cytotoxic agents with activity in breast cancer patients previously exposed to anthracyclines: current status and future prospects.

Piccart MJ, Raymond E, Aapro M, Eisenhauer EA, Cvitkovic E. Piccart MJ, et al. Eur J Cancer. 1995;31A Suppl 7:S1-10. doi: 10.1016/0959-8049(95)00266-l. Eur J Cancer. 1995. PMID: 8562183 Review. No abstract available.

4

Adjuvant systemic therapy for breast cancer.

Piccart MJ, Biganzoli L, Roy JA. Piccart MJ, et al. Curr Opin Oncol. 1996 Nov;8(6):478-84. doi: 10.1097/00001622-199611000-00006. Curr Opin Oncol. 1996. PMID: 8971467 Review.

5

Innovative approaches to the treatment of advanced breast cancer: introduction.

Norton L, Piccart MJ. Norton L, et al. Among authors: piccart mj. Semin Oncol. 1997 Aug;24(4 Suppl 10):S10-1-S10-2. Semin Oncol. 1997. PMID: 9274999 No abstract available.

6

Breast cancer therapies in development. A review of their pharmacology and clinical potential.

de Valeriola D, Awada A, Roy JA, Di Leo A, Biganzoli L, Piccart M. de Valeriola D, et al. Drugs. 1997 Sep;54(3):385-413. doi: 10.2165/00003495-199754030-00003. Drugs. 1997. PMID: 9279502 Review.

7

Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview.

Kaye SB, Piccart M, Aapro M, Francis P, Kavanagh J. Kaye SB, et al. Eur J Cancer. 1997 Nov;33(13):2167-70. doi: 10.1016/s0959-8049(97)00363-8. Eur J Cancer. 1997. PMID: 9470802 Review.

8

The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer.

Biganzoli L, Piccart MJ. Biganzoli L, et al. Among authors: piccart mj. Ann Oncol. 1997 Dec;8(12):1177-82. doi: 10.1023/a:1008295432012. Ann Oncol. 1997. PMID: 9496381 Free article. Review. No abstract available.

9

Breast cancer.

Aapro M, Piccart M. Aapro M, et al. Crit Rev Oncol Hematol. 1998 Feb;27(2):135-7. doi: 10.1016/s1040-8428(97)10021-x. Crit Rev Oncol Hematol. 1998. PMID: 9571316 Review. No abstract available.

10

The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned?

Piccart MJ, Biganzoli L, Di Leo A. Piccart MJ, et al. Eur J Cancer. 2000 Apr;36 Suppl 1:S4-10. doi: 10.1016/s0959-8049(99)00256-7. Eur J Cancer. 2000. PMID: 10785603 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

599 results

Search Page